While semaglutide only targets and binds to GLP-1 receptors, tirzepatide is a dual agonist that acts on both GLP-1 and GIP receptors
Although semaglutide is the generic name, most markets do not have approved generic counterparts
Healthcare providers may also prescribe multiple antidiabetic drugs to be used together to achieve or sustain target diabetes goals
Patients discontinuing semaglutide should work with healthcare providers to implement a structured discontinuation plan including nutrition guidance, regular physical activity (particularly resistance training to preserve lean muscle mass), and behavioral strategies to support weight maintenance and metabolic health
How It Works IGF-1 LR3 is administered via subcutaneous injection, typically once daily
Akturk HK, Dong F, Snell-Bergeon JK, Karakus KE, Shah VN